Verstuyft C - Search Results

1

Methemoglobinemia as a biomarker of dapsone-induced mania severity.

Colle R, Ait Tayeb AEK, Mesdom P, de Menthon M, Becquemont L, Verstuyft C, David DJ, Lambotte O, Corruble E. Colle R, et al. Among authors: verstuyft c. J Affect Disord. 2019 Jul 1;254:122-123. doi: 10.1016/j.jad.2018.12.123. Epub 2018 Dec 25. J Affect Disord. 2019. PMID: 30598189

2

Early acenocoumarol overanticoagulation among cytochrome P450 2C9 poor metabolizers.

Verstuyft C, Morin S, Robert A, Loriot MA, Beaune P, Jaillon P, Becquemont L. Verstuyft C, et al. Pharmacogenetics. 2001 Nov;11(8):735-7. doi: 10.1097/00008571-200111000-00013. Pharmacogenetics. 2001. PMID: 11692083

3

Dipyridamole enhances digoxin bioavailability via P-glycoprotein inhibition.

Verstuyft C, Strabach S, El-Morabet H, Kerb R, Brinkmann U, Dubert L, Jaillon P, Funck-Brentano C, Trugnan G, Becquemont L. Verstuyft C, et al. Clin Pharmacol Ther. 2003 Jan;73(1):51-60. doi: 10.1067/mcp.2003.8. Clin Pharmacol Ther. 2003. PMID: 12545143 Clinical Trial.

4

Digoxin pharmacokinetics and MDR1 genetic polymorphisms.

Verstuyft C, Schwab M, Schaeffeler E, Kerb R, Brinkmann U, Jaillon P, Funck-Brentano C, Becquemont L. Verstuyft C, et al. Eur J Clin Pharmacol. 2003 Apr;58(12):809-12. doi: 10.1007/s00228-003-0567-5. Epub 2003 Mar 1. Eur J Clin Pharmacol. 2003. PMID: 12698307

5

Frequency of cytochrome P450 2C9 allelic variants in the Chinese and French populations.

Yang JQ, Morin S, Verstuyft C, Fan LA, Zhang Y, Xu CD, Barbu V, Funck-Brentano C, Jaillon P, Becquemont L. Yang JQ, et al. Among authors: verstuyft c. Fundam Clin Pharmacol. 2003 Jun;17(3):373-6. doi: 10.1046/j.1472-8206.2003.00148.x. Fundam Clin Pharmacol. 2003. PMID: 12803577

6

Measurement of CYP2D6 and CYP3A4 activity in vivo with dextromethorphan: sources of variability and predictors of adverse effects in 419 healthy subjects.

Funck-Brentano C, Boëlle PY, Verstuyft C, Bornert C, Becquemont L, Poirier JM. Funck-Brentano C, et al. Among authors: verstuyft c. Eur J Clin Pharmacol. 2005 Dec;61(11):821-9. doi: 10.1007/s00228-005-0051-5. Epub 2005 Nov 17. Eur J Clin Pharmacol. 2005. PMID: 16315033

7

Genetic polymorphism of vitamin K epoxide reductase (VKORC1) 1173C>T in a Chinese and a Caucasian population.

Larramendy-Gozalo C, Yang JQ, Verstuyft C, Bodin L, Dubert L, Zhang Y, Xu C, Fan L, Jaillon P, Becquemont L. Larramendy-Gozalo C, et al. Among authors: verstuyft c. Basic Clin Pharmacol Toxicol. 2006 Jun;98(6):611-3. doi: 10.1111/j.1742-7843.2006.pto_440.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 16700826 Free article. No abstract available.

8

[Pharmacogenetics and interindividual variability in drug response: cytochrome P-450 2C9 and coumarin anticoagulants].

Becquemont L, Verstuyft C, Jaillon P. Becquemont L, et al. Among authors: verstuyft c. Bull Acad Natl Med. 2006 Jan;190(1):37-49; discussion 50-3. Bull Acad Natl Med. 2006. PMID: 16878445 French.

9

Amiodarone interacts with simvastatin but not with pravastatin disposition kinetics.

Becquemont L, Neuvonen M, Verstuyft C, Jaillon P, Letierce A, Neuvonen PJ, Funck-Brentano C. Becquemont L, et al. Among authors: verstuyft c. Clin Pharmacol Ther. 2007 May;81(5):679-84. doi: 10.1038/sj.clpt.6100098. Epub 2007 Feb 14. Clin Pharmacol Ther. 2007. PMID: 17301736 Clinical Trial.

10

Modelling the influence of MDR1 polymorphism on digoxin pharmacokinetic parameters.

Comets E, Verstuyft C, Lavielle M, Jaillon P, Becquemont L, Mentré F. Comets E, et al. Among authors: verstuyft c. Eur J Clin Pharmacol. 2007 May;63(5):437-49. doi: 10.1007/s00228-007-0269-5. Epub 2007 Mar 13. Eur J Clin Pharmacol. 2007. PMID: 17404720 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters